DR Congo approves ‘MANACOVID’ for COVID-19 treatment

The Luozi pharmaceutical research centre (CRPL), on Tuesday, approved the “MANACOVID” drug to treat the coronavirus (COVID-19) in DR Congo. A statement issued in Kinshasa said...